Ocugen agrees to distribute Bharat Biotech s Covid-19 vaccine in the US pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.
3 Min Read
NEW DELHI (Reuters) - India’s drug regulator on Friday approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use, two sources with knowledge of the matter told Reuters.
FILE PHOTO: Vials with a sticker reading, COVID-19 / Coronavirus vaccine / Injection only and a medical syringe are seen in front of a displayed AstraZeneca logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/File Photo
The decision clears the vaccine’s rollout in the world’s second-most populous country which, after the United States, has the highest number of COVID-19 infections.
India wants to start administering the vaccine soon, most likely by Wednesday, said one of the sources, both of whom declined to be named ahead of an official announcement expected later in the day.
Pfizer wants India to order Covid-19 vaccine before pursuing approval: Report
Pfizer wants India to order Covid-19 vaccine before pursuing approval: Report
Pfizer will request India to approve its coronavirus vaccine if the government commits to buying shots, the US drugmaker told Reuters on Monday.
advertisement
UPDATED: January 26, 2021 07:57 IST
Pfizer was the first company to seek emergency-use authorisation (EUA) for a Covid-19 vaccine in India. (Image: AFP)
Pfizer Inc will pursue its request for India to approve its Covid-19 vaccine if the government commits to buying shots, the U.S. drugmaker told Reuters on Monday, even as global supplies tighten.
Govt vows free vaccine for all
At a time when Pfizer Inc has tightened the global supplies of vaccines because of limited supplies, the American drug major has said that it will continue its request to seek approvals for coronavirus vaccine in India only if the government committed to purchasing the shots first.
It should be noted that Pfizer was the first pharma company in the world to seek emergency-use authorisation (EUA) for a Covid-19 vaccine not only in India but in other countries as well.
But government in India instead gave a go-ahead to two vaccines – one indigenously produced by Bharat Biotech while the other developed by Oxford University-AstraZeneca – owing to their cheaper rates in comparison to those developed by Pfizer and the lesser maintenance requirement as Pfizer ones need a cold storage processor of a minimum -70 degree Celsius for effective sustenance.
3 Min Read
NEW DELHI (Reuters) - Pfizer Inc will pursue its request for India to approve its COVID-19 vaccine if the government commits to buying shots, the U.S. drugmaker told Reuters on Monday, even as global supplies tighten.
FILE PHOTO: A vial and sryinge are seen in front of a displayed Pfizer and Biontech logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Pfizer was the first company to seek emergency-use authorisation (EUA) for a COVID-19 vaccine in India, but the government this month approved two much cheaper shots - one from Oxford University/AstraZeneca and another developed at home by Bharat Biotech with the Indian Council of Medical Research.